APPLICATION OF CART19 FOR DEPLETING NORMAL B-CELLS FOR TOLERANCE INDUCTION

摘要

The present invention relates to compositions and methods for inducing tolerance in humans. The invention includes the introduction of a genetically modified T cell expressing a CAR, wherein the CAR comprises an antigen binding domain, a transmembrane domain, a co-stimulatory signaling region, and a CD3 zeta signaling domain.